Biotech

Alpha-Ketoglutarate Enhances Adipose-Derived Stem Cells Survival in Wound Healing by Hypoxia-Inducible Factor 1-Alpha-Mediated Redox Homeostasis and Glycogen-Dependent Bioenergetics

by

BACKGROUND Adipose-derived stem cells (ADSCs) hold significant therapeutic potential for regenerative medicine, particularly in wound healing, owing to their multipotency, paracrine activity, and relative abundance. However, the clinical application of ADSC-based therapies is substantially limited by the harsh microenvironment of acute wounds, characterized by hypoxia, nutrient deprivation, and oxidative stress, which leads to massive apoptotic … Read more

New Oral Therapies Signal Shift in Cardiometabolic Care

by

A new experimental cholesterol-lowering pill and recent advances in oral diabetes treatments are reinforcing a broader shift toward earlier, less invasive management of cardiometabolic disease, as drugmakers and clinicians focus on prevention, adherence, and risk reduction in high-risk populations. “There are other pills that patients can add to their statins, but none come close to … Read more

AI Startup Expert Intelligence Raises $4.7 Million to Automate Regulated Laboratory Data Analysis with AI

by

Archyde Artificial Intelligence Startup Expert intelligence Secures $4.7 Million in Seed Funding San Francisco, california – Expert Intelligence, a pioneering start-up focused on Artificial Intelligence solutions for regulated laboratory environments, has… You can read the full story here: AI Startup Expert Intelligence Raises $4.7 Million to Automate Regulated Laboratory Data Analysis with AI. Source link

QT Sense raises €4 million to develop quantum platform for cancer, sepsis and arthritis research

by

Groningen-based BioTech startup QT Sense has raised €4 million to accelerate Quantum Nuova, their platform that uses quantum technology to track cellular stress within individual cells in real time – enabling scientists to watch cellular processes as they happen. The funding combines a €3 million Seed round led by Cottonwood Technology Fund, alongside follow-on funding from … Read more

This Chinese Startup Wants to Build a New Brain-Computer Interface—No Implant Required

by

China’s brain-computer interface industry is growing fast, and the newest company to emerge from the country is aiming to access the brain without the use of invasive implants. Gestala, newly founded in Chengdu with offices in Shanghai and Hong Kong, plans to use ultrasound technology to stimulate—and eventually read from—the brain, according to CEO and … Read more

Calling Innovators & Med Tech Developers: Apply to Be Featured at the 2026 Respiratory Innovation Summit

by

Newswise — NEW YORK, NY – Jan. 20, 2026 – Researchers, clinicians, pharmaceutical innovators, medical technology developers, and entrepreneurs are invited to bring their most promising ideas to the 2026 Respiratory Innovation Summit (RIS), hosted by the American Thoracic Society.  RIS convenes global leaders across industry, investment, academia, government, and clinical medicine, offering a unique … Read more

AstriVax Therapeutics Initiates Clinical Development of

by

Third asset to advance into clinical trials, validating broad potential of Launch-iT platform All subjects treated with first dose of AVX70371 Launch-iT, as part of multiple dosing schedule Potential first-in-class treatment that could form part of functional cure for over 250 million patients suffering from chronic hepatitis B virus (HBV) infection Leuven, Belgium, June 5, … Read more

GlycoEra Raises $130M for Protein Degraders

by

Archyde: Latest World News, Economy, Entertainment, Health, Technology & Sports Updates GlycoEra Secures $130 Million to Revolutionize Autoimmune Disease treatment Table of Contents 1. GlycoEra Secures $130 Million to Revolutionize Autoimmune Disease treatment 2. Targeting the Root of Autoimmune Disorders 3.… You can read the full story here: GlycoEra Raises $130M for Protein Degraders. Source … Read more

Neutrophils in the Immune System Help Build Healthy Skin

by

Newswise — Neutrophils, the most abundant immune cells in our bodies, are known for their destructive roles: killing pathogens, clearing out infections, and, sometimes to our detriment, wreaking havoc on surrounding tissues in the process. But now, scientists at Yale School of Medicine (YSM), have discovered a new role for neutrophils, one that involves the … Read more

NeuroSigma Announces New Clinical Trial of Monarch eTNS

by

Trial to be conducted at UCLA and funded by a grant from National Institute on Alcohol Abuse and Alcoholism (NIAAA) First phase of trial will enroll up to 30 children ages 8 – 12 with exposure to alcohol during gestation to receive treatment with the Monarch Upon successful completion of Phase I, investigators will proceed … Read more